Nanommune

Nanommune Inc is a biotechnology company focused on developing cutting-edge tools for the medical and research communities. Nanommune's high-throughput proteomic antigen-specific microarray platform revolutionizes diagnostics, serological surveillance, and vaccine research by providing the global health community with rapid, highly accurate, and rapidly deployable toolkits to address critically important needs. The company’s pathogen-specific microarrays can be quickly deployed on a large scale, serving as an essential tool in combating emerging infectious diseases. In addition to the microarray platform, Nanommune also offers qPCR test kits and proprietary vaccine discovery kits to help fight emerging infectious diseases worldwide.